Leg paralysis after AstraZeneca COVID-19 vaccination diagnosed as neuralgic amyotrophy of the lumbosacral plexus: a case report
The ongoing global administration of vaccines for coronavirus disease 2019 (COVID-19) means that increasing numbers of patients are likely to present with post-vaccination complications. We describe the first reported case of neuralgic amyotrophy (NA) involving the lumbosacral plexus occurring after...
Guardado en:
Autores principales: | Se Il Kim, Hung Youl Seok, Jaehyuck Yi, Jang Hyuk Cho |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
SAGE Publishing
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/370dc389bc6c4ae197e22486c145b3ac |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Reactogenicity and Immunogenicity of the Pfizer and AstraZeneca COVID-19 Vaccines
por: Waleed H. Mahallawi, et al.
Publicado: (2021) -
New Tendencies in the Development of the EU Competition Law – the AstraZeneca case
por: K. V. Entin
Publicado: (2011) -
Herpes‐like skin lesion after AstraZeneca vaccination for COVID‐19: A case report
por: Mohammadreza Ardalan, et al.
Publicado: (2021) -
Possible Risk of Thrombotic Events following Oxford-AstraZeneca COVID-19 Vaccination in Women Receiving Estrogen
por: Ava Soltani Hekmat, et al.
Publicado: (2021) -
Severity assessment of single-dose Oxford-AstraZeneca vaccinated individuals infected with severe acute respiratory syndrome coronavirus 2 in Southeast Bangladesh
por: Eaftekhar Ahmed Rana, et al.
Publicado: (2021)